Potential Rx Economic Claims To Health Plans Presented In Tufts Analysis
This article was originally published in The Pink Sheet Daily
Executive Summary
In a recently published article, Tufts researchers present 10 hypothetical health care economic claims for drugs and consider how they might fit the requirements of Section 114 of the FDA Modernization Act.